Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.04 USD | 0.00% | +15.65% | -2.80% |
14/05 | Transcript : MiNK Therapeutics, Inc., Q1 2024 Earnings Call, May 14, 2024 | |
14/05 | MiNK Therapeutics, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.80% | 36.09M | |
+33.37% | 50.85B | |
+1.55% | 42.82B | |
+48.83% | 42.03B | |
-4.22% | 29.55B | |
+11.57% | 26.11B | |
-21.00% | 19.13B | |
+7.36% | 13.05B | |
+28.30% | 12.16B | |
+23.80% | 12.08B |
- Stock Market
- Equities
- INKT Stock
- News MiNK Therapeutics, Inc.
- B. Riley Starts MiNK Therapeutics at Buy with $24 PT, Notes 'Attractive' Valuation, Disruptive Potential of iNKT Platform